SG Issuer Société Anonyme Stock

Certificat

DE000SR7YJH9

Real-time Boerse Frankfurt Warrants 05:31:56 2024-07-11 am EDT
980.1 EUR +0.70% Intraday chart for SG Issuer Société Anonyme
Current month-0.65%
1 month-1.20%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 980.1 +0.70%
24-07-10 973.3 -0.42%
24-07-09 977.4 +0.27%
24-07-08 974.7 -0.13%
24-07-05 976 +0.32%

Real-time Boerse Frankfurt Warrants

Last update July 11, 2024 at 05:31 am EDT

More quotes

Static data

Product type100% Guarantee Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SR7YJH
ISINDE000SR7YJH9
Date issued 2024-04-19
Strike 222.1 CHF
Maturity 2027-10-19 (1195 Days)
Parity 0.22 : 1
Emission price 1,010
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1,010
Lowest since issue 972.9
Spread 10
Spread %1.01%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249 CHF
Average target price
274 CHF
Spread / Average Target
+10.04%
Consensus